Pregabalin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Pregabalin. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Dizziness | 37% |
| Somnolence | 25% |
| Peripheral edema | 16% |
| Dry mouth | 15% |
| Infection | 14% |
| Fatigue | 11% |
| Edema peripheral | 10.4% |
| Headache | 9% |
| Ataxia | 9% |
| Blurry vision‡ | 9% |
| Nasopharyngitis | 8.2% |
| Abnormal gait | 8% |
| Weight gain | 7% |
| Confusion | 7% |
| Vision blurred | 6.6% |
| Edema | 6% |
| Thinking abnormal† | 6% |
| Pain | 5% |
| Accidental injury | 5% |
| Constipation | 5% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
1 INDICATIONS AND USAGE Pregabalin capsules are indicated for: • Management of neuropathic pain associated with diabetic peripheral neuropathy • Management of postherpetic neuralgia • Adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older • Management of fibromyalgia • Management of neuropathic pain associated with spinal cord injury Pediatric use information is approved for Pfizer's LYRICA (pregabalin) Capsules and Oral Solution products. However, due to Pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.